Annual Shareholders Equity
$13.88 M
+$456.00 K+3.40%
31 December 2023
Summary:
Galmed Pharmaceuticals annual stockholders equity is currently $13.88 million, with the most recent change of +$456.00 thousand (+3.40%) on 31 December 2023. During the last 3 years, it has fallen by -$30.27 million (-68.57%). GLMD annual shareholders equity is now -84.21% below its all-time high of $87.89 million, reached on 31 December 2018.GLMD Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$18.44 M
+$6.65 M+56.41%
30 September 2024
Summary:
Galmed Pharmaceuticals quarterly stockholders equity is currently $18.44 million, with the most recent change of +$6.65 million (+56.41%) on 30 September 2024. Over the past year, it has increased by +$2.89 million (+18.58%). GLMD quarterly shareholders equity is now -79.75% below its all-time high of $91.04 million, reached on 30 June 2018.GLMD Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLMD Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.4% | +18.6% |
| 3 y3 years | -68.6% | -51.1% |
| 5 y5 years | -84.2% | -76.2% |
GLMD Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -68.6% | +3.4% | -51.1% | +74.7% |
| 5 y | 5 years | -84.2% | +3.4% | -76.2% | +74.7% |
| alltime | all time | -84.2% | +801.3% | -79.8% | +1045.0% |
Galmed Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $18.44 M(+56.4%) |
| June 2024 | - | $11.79 M(-7.6%) |
| Mar 2024 | - | $12.76 M(-8.1%) |
| Dec 2023 | $13.88 M(+3.4%) | $13.88 M(-10.7%) |
| Sept 2023 | - | $15.55 M(+47.3%) |
| June 2023 | - | $10.55 M(-12.0%) |
| Mar 2023 | - | $11.99 M(-10.7%) |
| Dec 2022 | $13.42 M(-56.0%) | $13.42 M(-14.8%) |
| Sept 2022 | - | $15.75 M(-24.0%) |
| June 2022 | - | $20.71 M(-15.0%) |
| Mar 2022 | - | $24.37 M(-20.1%) |
| Dec 2021 | $30.50 M(-30.9%) | $30.50 M(-19.1%) |
| Sept 2021 | - | $37.68 M(-16.3%) |
| June 2021 | - | $45.00 M(-15.0%) |
| Mar 2021 | - | $52.96 M(+19.9%) |
| Dec 2020 | $44.15 M(-36.8%) | $44.15 M(-17.7%) |
| Sept 2020 | - | $53.66 M(-10.4%) |
| June 2020 | - | $59.88 M(-6.6%) |
| Mar 2020 | - | $64.10 M(-8.2%) |
| Dec 2019 | $69.85 M | $69.85 M(-9.8%) |
| Sept 2019 | - | $77.42 M(-4.9%) |
| June 2019 | - | $81.39 M(-4.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $84.93 M(-3.4%) |
| Dec 2018 | $87.89 M(+456.5%) | $87.89 M(-3.1%) |
| Sept 2018 | - | $90.75 M(-0.3%) |
| June 2018 | - | $91.04 M(+569.3%) |
| Mar 2018 | - | $13.60 M(-13.9%) |
| Dec 2017 | $15.79 M(+42.6%) | $15.79 M(+141.8%) |
| Sept 2017 | - | $6.53 M(+4.6%) |
| June 2017 | - | $6.24 M(-24.8%) |
| Mar 2017 | - | $8.30 M(-25.1%) |
| Dec 2016 | $11.07 M(-48.6%) | $11.07 M(-28.7%) |
| Sept 2016 | - | $15.53 M(+7.7%) |
| June 2016 | - | $14.43 M(-19.3%) |
| Mar 2016 | - | $17.88 M(-17.0%) |
| Dec 2015 | $21.55 M(-31.4%) | $21.55 M(-14.0%) |
| Sept 2015 | - | $25.06 M(-8.6%) |
| June 2015 | - | $27.41 M(-7.0%) |
| Mar 2015 | - | $29.49 M(-6.1%) |
| Dec 2014 | $31.41 M(-1709.8%) | $31.41 M(-5.5%) |
| Sept 2014 | - | $33.25 M(-8.5%) |
| June 2014 | - | $36.35 M(-4.2%) |
| Mar 2014 | - | $37.95 M(-2045.3%) |
| Dec 2013 | -$1.95 M(-1.4%) | -$1.95 M |
| Dec 2012 | -$1.98 M | - |
FAQ
- What is Galmed Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals annual shareholders equity year-on-year change?
- What is Galmed Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Galmed Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of GLMD is $13.88 M
What is the all time high annual shareholders equity for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high annual stockholders equity is $87.89 M
What is Galmed Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, GLMD annual stockholders equity has changed by +$456.00 K (+3.40%)
What is Galmed Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of GLMD is $18.44 M
What is the all time high quarterly shareholders equity for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high quarterly stockholders equity is $91.04 M
What is Galmed Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, GLMD quarterly stockholders equity has changed by +$2.89 M (+18.58%)